-+ 0.00%
-+ 0.00%
-+ 0.00%

SCYNEXIS INITIATES DOSING IN PHASE 1 TRIAL OF SCY-247, A SECOND-GENERATION FUNGERP CANDIDATE FOR INVASIVE FUNGAL INFECTIONS

Reuters·12/18/2024 13:00:00

Please log in to view news